View in EDS

Seroprevalence of Immunoglobulin G against measles and rubella over a 12-year period (2009-2021) in Kilifi, Kenya and the impact of the Measles-Rubella (MR) vaccine campaign of 2016.

Saved in:
Bibliographic Details
Title: Seroprevalence of Immunoglobulin G against measles and rubella over a 12-year period (2009-2021) in Kilifi, Kenya and the impact of the Measles-Rubella (MR) vaccine campaign of 2016.
Authors: Mburu CN; Epidemiology and Demography Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya; Department of Infectious Diseases Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom. Electronic address: mburucaroline@gmail.com., Ojal J; Epidemiology and Demography Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Selim R; Epidemiology and Demography Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Ombati R; Epidemiology and Demography Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Akech D; Epidemiology and Demography Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Karia B; Epidemiology and Demography Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Tuju J; Epidemiology and Demography Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Sigilai A; Epidemiology and Demography Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Smits G; Department of Immunosurveillance, Centre for Infectious Diseases Control, National Institute of Public Health and the Environment (RIVM), the Netherlands., van Gageldonk PGM; Department of Immunosurveillance, Centre for Infectious Diseases Control, National Institute of Public Health and the Environment (RIVM), the Netherlands., van der Klis FRM; Department of Immunosurveillance, Centre for Infectious Diseases Control, National Institute of Public Health and the Environment (RIVM), the Netherlands., Flasche S; Department of Infectious Diseases Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom; Charite Centre for global Health, Charite-Universitaetsmedizin, Berlin, Germany., Kagucia EW; Epidemiology and Demography Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Scott JAG; Epidemiology and Demography Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya; Department of Infectious Diseases Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom., Adetifa IMO; Epidemiology and Demography Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya; Department of Infectious Diseases Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Source: Vaccine [Vaccine] 2025 Aug 13; Vol. 61, pp. 127425. Date of Electronic Publication: 2025 Jun 21.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-2518
DOI:10.1016/j.vaccine.2025.127425